AstraZeneca sues Mylan after Faslodex generic bid

08-08-2016

AstraZeneca sues Mylan after Faslodex generic bid

garajstock / Shutterstock.com

AstraZeneca has sued Mylan for allegedly infringing its patents covering the drug Faslodex (fulvestrant).


AstraZeneca, Mylan, patent, Faslodex, fulvestrant, ANDA, FDA

LSIPR